Tenet Healthcare Lifts 2025 Outlook as Adjusted Earnings and Cash Flow Show Strong Growth

Third Quarter Results Reflect Accelerating Adjusted Profitability and Cash Flow

Tenet Healthcare Corporation (NYSE: THC) reported a strong third quarter 2025, marked by a 26% increase in adjusted diluted earnings per share to $3.70 versus $2.93 in the same period last year, and a 12.4% rise in consolidated adjusted EBITDA to $1.10 billion. Notably, free cash flow for the first nine months climbed to $2.16 billion from $1.78 billion a year earlier. The company’s disciplined operating focus, higher acuity patient mix, and strategic facility acquisitions are fueling the momentum, leading management to raise the 2025 adjusted EBITDA outlook by $50 million at the midpoint.

Both Ambulatory and Hospital Segments Post Higher Margins and Earnings

The outperformance is broad-based, with the Ambulatory Care segment achieving $492 million in adjusted EBITDA—up 12.1%—and maintaining high margins of 38.6%. Hospital Operations saw adjusted EBITDA increase by 12.6% to $607 million, with margin expansion from 13.5% to 15.1%. Same-facility net patient service revenues rose sharply in the Ambulatory segment (up 8.3%), and net revenue per case in both segments benefited from favorable payer and service mix.

Full-Year 2025 Outlook Raised as Management Signals Continued Momentum

Tenet now expects 2025 adjusted EBITDA between $4.47 billion and $4.57 billion, reflecting improved performance across segments. Adjusted free cash flow is projected between $2.43 billion and $2.63 billion, reinforcing financial flexibility. For shareholders, buybacks continue, with $1.19 billion spent year-to-date, and net debt leverage down to 2.30x adjusted EBITDA. Ambulatory system-wide revenue growth is now seen rising 5.5%–7.5%, and inpatient admissions in hospitals up 2.0%–3.0% over the year.

Operating Discipline and Segment Growth Are Driving Sustainable Results

Tenet’s higher operating margins, lower net debt leverage, and robust free cash flow signal a business firing on multiple cylinders. With the U.S. healthcare landscape still shifting, management’s focus on higher-acuity and ambulatory services appears well-timed for industry trends. Both investor returns—through share repurchases—and improved credit metrics further underscore a period of strong, sustainable financial health.

Key Takeaways for Investors

Investors and analysts will be watching Tenet’s ability to sustain these trends amid continued market and regulatory changes. Management’s webcast later today should provide additional clarity on strategic initiatives, while improving fundamentals suggest further upside to current guidance may not be out of reach.

Contact Information:

If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.

About the Publisher - Marketchameleon.com:

Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.

NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.

The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.

Disclosure: This article was generated with the assistance of AI